价格

Antisense agents

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
- EP 4013767 A4
  申请人: IONIS PHARMACEUTICALS INC优先权: 2019
  CN
  EP
  US
  WO
  9 件公开
- US 20250154506 A1
  申请人: IONIS PHARMACEUTICALS INC优先权: 2022
  US
- EP 4532724 A4
  申请人: IONIS PHARMACEUTICALS INC优先权: 2022
  EP
Antisense oligonucleotides against cPLA2, compositions and uses thereof
US 8242255 B2申请人: LEVY RACHEL优先权: 2004
CN
EP
US
WO
8 件公开
AChE antisense deoxyoligonucleotide as an anti-inflammatory agent
EP 2599489 A1申请人: YISSUM RES DEV CO优先权: 2003
EP
US
WO
7 件公开
IL-34 ANTISENSE AGENTS AND METHODS OF USING SAME
EP 4341403 A1申请人: NOGRA PHARMA LTD优先权: 2021
CN
EP
US
WO
6 件公开
AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
EP 3118316 A1申请人: UNIVERSITÉ DE MONS优先权: 2010
EP
US
6 件公开
DELIVERY OF AGENTS USING INTERFERING NANOPARTICLES
US 2011263514 A1申请人: SANFORD BURNHAM MED RES INST优先权: 2010
US
WO
5 件公开
ALPHA-V BETA-6 INTEGRIN LIGANDS FOR EXTRAHEPATIC DELIVERY
EP 4605008 A1申请人: ALNYLAM PHARMACEUTICALS INC优先权: 2022
CN
EP
US
WO
4 件公开
MTOR THERAPEUTICS FOR CANCER
EP 4661908 A1申请人: GMP BIOTECHNOLOGY LTD优先权: 2023
CN
EP
US
WO
4 件公开
ANTISENSE OLIGONUCLEOTIDE AGENTS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP3/NLRP1 EXPRESSION OR ACTIVATION
EP 4673547 A2申请人: MOLECULAR AXIOM LLC优先权: 2023
CN
EP
US
WO
4 件公开
Uses of DNA-PK
US 7700568 B2申请人: SLOAN KETTERING INST CANCER优先权: 2000
US
4 件公开

药物

Antisense agents

专利

LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF